文献速递小儿耳鼻咽喉耳科与耳神经

澳大利亚新生儿听力筛查项目的经济学评价:一项研究内成本-效果分析

An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis.
PubMed 文献 · Ear Hear · 2022-01-01

该研究从澳大利亚医疗系统视角,基于自然实验的真实数据,对普遍新生儿听力筛查(UNHS)与目标性筛查进行为期5年的研究内成本-效果分析。结果显示,UNHS每诊断一名儿童平均多花费22000澳大利亚元,多获得0.45个质量调整生命年(QALY),增量成本-效果比(ICER)为每获得一个QALY需48000澳大利亚元。作者认为筛查成本是成本-效果的关键驱动因素,多数结局在两组间无显著差异,且因随访期短ICER可能被高估。

要点

  • UNHS每诊断一名儿童平均多花费22000澳大利亚元,多获得0.45个QALY,ICER为每QALY 48000澳大利亚元。
  • 在每QALY 60000澳大利亚元的支付意愿阈值下,UNHS比目标性筛查更具成本-效果的概率为69%。
  • 语言结局的ICER介于每提高1分3900澳大利亚元(表达性语言评分)至83500澳大利亚元(韦氏非言语能力量表)之间。

核心结论

  • 该评价表明研究内经济学评价有助于理解UNHS项目在澳大利亚背景下的资金价值。
  • 筛查成本是成本-效果结果的关键驱动因素。
  • UNHS与目标性筛查组之间多数结局无显著差异。
  • 由于随访期短,ICER可能被高估;需要进一步研究纳入长期资源使用和结局数据、迟诊、严重程度等级间的转换与缓解以及诊断和治疗时机。

研究设计与样本

  • 研究设计为研究内成本-效果分析,采用自然实验的真实世界数据。
  • 评价采用澳大利亚医疗系统视角,时间范围为5年。
  • 效用值通过健康效用指数马克III(Health Utilities Index Mark III)的应答估算。
  • 筛查成本基于维多利亚婴儿听力筛查项目估算,持续成本基于行政数据估算,听力服务相关成本使用外部数据源估算。
  • 缺失数据采用多重插补法处理。

主要发现

  • 与目标性筛查相比,UNHS每诊断一名儿童平均多花费22000澳大利亚元,并多获得0.45个QALY,至5年时ICER为每获得一个QALY需48000澳大利亚元。
  • 语言结局的ICER介于每提高1分3900澳大利亚元(表达性语言评分)至83500澳大利亚元(韦氏非言语能力量表)之间。
  • 在每QALY 60000澳大利亚元的支付意愿阈值下,UNHS比目标性筛查更具成本-效果的概率为69%。
  • ICER对筛查成本最为敏感。
  • UNHS与目标性筛查组之间多数结局无显著差异。

关键数值与推荐

  • 结局指标包括质量调整生命年(QALY)和四项语言与交流相关结局:皮博迪图片词汇测验、韦氏非言语能力量表、渐进成就测验以及基于学前语言量表的综合、表达和总语言评分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 由于随访期短,ICER可能被高估。
  • 需要进一步研究纳入长期资源使用和结局数据、迟诊、严重程度等级间的转换与缓解以及诊断和治疗时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Hearing loss is one of the most prevalent congenital disorders among children. Many countries have implemented universal newborn hearing screening (UNHS) for the early diagnosis and treatment of hearing loss. Despite widespread implementation, the value for money of UNHS is unclear due to lack of cost and outcomes data from rigorous study designs. The objective of this research is to conduct a within-study cost-effectiveness analysis of UNHS compared with targeted screening (targeting children with risk factors of hearing loss) from the Australian healthcare system perspective. This evaluation is the first economic evaluation to assess the cost-effectiveness of UNHS compared to targeted screening using real-world data from a natural experiment. DESIGN: The evaluation assumed the Australian healthcare system perspective and considered a time horizon of 5 years. Utilities were estimated using responses to the Health Utilities Index Mark III. Screening costs were estimated based on the Victorian Infant Hearing Screening Program. Ongoing costs were estimated based on administrative data, while external data sources were used to estimate costs related to hearing services. Missing data were handled using the multiple imputation method. Outcome measures included quality-adjusted life years (QALYs) and four language and communication-related outcomes: Peabody Picture Vocabulary Test, Wechsler Nonverbal Scale of Ability, Progressive Achievement Test, and comprehensive, expressive, and total language scores based on the Preschool Language Scale. RESULTS: On average, the UNHS cost an extra Australian dollar (A$)22,000 per diagnosed child and was associated with 0.45 more QALYs per diagnosed child compared with targeted screening to 5 years, resulting in an incremental cost-effectiveness ratio (ICER) of A$48,000 per QALY gained. The ICERs for language outcomes lay between A$3,900 (for expressive language score) and A$83,500 per one-point improvement in language score (for Wechsler Nonverbal Scale of Ability). UNHS had a 69% probability of being more cost-effective compared to targeted screening at a willingness to pay threshold of A$60,000 per QALY gained. ICERs were most sensitive to the screening costs. CONCLUSIONS: The evaluation demonstrated the usefulness of a within-study economic evaluation to understand the value for money of the UNHS program in the Australian context. Findings from this evaluation suggested that screening costs were the key driver of cost-effectiveness results. Most outcomes were not significantly different between UNHS and targeted screening groups. The ICER may be overestimated due to the short follow-up period. Further research is warranted to include long-term resource use and outcome data, late diagnosis, transition and remission between severity levels, and timing of diagnosis and treatment.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Sharma R, Gu Y, Sinha K, et al. An Economic Evaluation of Australia's Newborn Hearing Screening Program: A Within-Study Cost-Effectiveness Analysis. Ear Hear. 2022. PMID: 34772837. doi:10.1097/AUD.0000000000001153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。